Patent Assignment
Reel/Frame 062980/0041
Merger and Change of Name
Recorded: 2023-03-14
Pages: 6
Assignors
SHIRE-NPS PHARMACEUTICALS, INC.
Executed: 2022-07-28
TAKEDA PHARMACEUTICALS U.S.A., INC.
Executed: 2022-07-28
Assignee
TAKEDA PHARMACEUTICALS U.S.A., INC.
95 HAYDEN AVENUE, LEXINGTON, MASSACHUSETTS, 02421
Covered Properties
(3)
Parathyroid Hormone Variants
Formulations for Improved Stability of Recombinant Human Parathyroid Hormone
Application:
17/264,720 →
Publication:
US 2021/0315978
Parathyroid Hormone Variants
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 1, 2021
From: DIXIT, NITIN; NGUYEN, VINH; SOUILLAC, PIERRE; BASU, SUJIT
To: SHIRE-NPS PHARMACEUTICALS, INC.
Reel/Frame 055092/0902 →
Assignment of Assignor's Interest
Apr 15, 2021
From: PAN, CLARK; NORTON, ANGELA; HOLMES, KEVIN; LLOYD, DAVID BRUCE
To: SHIRE-NPS PHARMACEUTICALS, INC.
Reel/Frame 055948/0608 →
Assignment of Assignor's Interest
Jun 16, 2023
From: TAKEDA PHARMACEUTICALS U.S.A., INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 063977/0474 →
Assignment of Assignor's Interest
Jun 27, 2023
From: PAN, CLARK; NORTON, ANGELA; HOLMES, KEVIN; LLOYD, DAVID BRUCE
To: SHIRE-NPS PHARMACEUTICALS, INC.
Reel/Frame 064126/0011 →